Table 1 Questionnaire
Question number | Question | Possible answers: |
|---|---|---|
1. | Age | ____ years |
2. | Sex | • Male • Female |
3. | Radiotherapy experience | ____ years |
4. | Do you feel that there is enough evidence to support heart sparing for breast cancer patients? | • Yes • No • I don’t know |
5. | Which dose do you consider a “safe” heart dose? | ________ Gy |
6. | Which patients do you think will profit from heart sparing techniques? | • all patients • patients who underwent cardiotoxic systemic therapy • patients with known arterial hypertension • patients with known coronary heart disease • patients < 50 y.o • patients <60 y.o. • patients <70 y.o. • patients <80 y.o. • patients <90 y.o. • other (please specify):_______ |
7. | Which dosimetric parameter do you consider most important? | • V10 (the volume that receives 10 Gy or more) • V20 • V30 • V40 • V50 • Dmean • Dmax • other (please specify):_______ |
8. | For which structures are the previously chosen parameters important for you? | • whole heart • left anterior descending artery • right coronary artery • ramus circumflexus • left ventricle • right ventricle • left atrium • right atrium • other (please specify):_______ |
9. | You would offer heart sparing techniques to all breast cancer patients if: | • It would be less time/ resource consuming. • There would be better evidence in literature. • I could decide by myself. • The reimbursing would be better. • I would not offer heart-sparing techniques to all patients. • other (please specify):_______ |
10. | Do you feel that there is enough evidence to support heart sparing for other cancer patients (e.g. Hodgkin lymphoma)? | • Yes • No • I don’t know |
11. | Do you perform heart sparing for other cancer patients (e.g. Hodgkin lymphoma)? | • Yes • No |
12. | If yes, for which entities? | _________________ |